Semaglutide, a glucagon like peptide-one (GLP-1) receptor agonist, is out there as monotherapy in both subcutaneous together with oral dosage variety (first authorised oral GLP-one receptor agonist). It has been authorized like a second line remedy option for better glycaemic Manage in kind 2 diabet